Fortrea Holdings Inc. (FTRE): Total Liabilities
$2.15B
As of 2025-12-31
$2.19B
As of 2026-06-30
+31.6%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.15B | -2.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $2.22B | -15.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $2.62B | +177.0% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $945.30M | n/a | 2024-03-13, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.15B | -2.9% |
| Natera, Inc. (NTRA) | 2025-12-31 | $685.93M | +47.4% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $2.40B | +11.6% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.11B | +30.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $548.36M | -11.7% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $9.76B | -5.4% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $96.44M | -22.3% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗